Artwork

Indhold leveret af Vial. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Vial eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Episode 39: Lucas Siow - CEO & Co-Founder at ProteinQure

15:05
 
Del
 

Manage episode 382347669 series 3526490
Indhold leveret af Vial. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Vial eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Embark on a journey into the forefront of biotech with Lucas Siow, the visionary behind ProteinQure, as he unveils the impact of his computational platform on peptide therapeutics and delves into the art of team building. Explore the fusion of medicinal chemistry and high throughput screens, discover the essence of benchmarking in drug discovery, and gain insights into creating a versatile, learning-focused team in the biotech landscape from their Toronto base.
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.

Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.
🎧 Stay in the Loop!
For the latest news and updates, visit our website: https://vial.com
Follow us on social media for real-time insights:
Twitter: https://twitter.com/VialTrials
LinkedIn: https://www.linkedin.com/company/vialtrials

  continue reading

Kapitler

1. Episode 39: Lucas Siow - CEO & Co-Founder at ProteinQure (00:00:00)

2. Advancing Peptide Therapeutics in Biotech (00:00:06)

3. Building a Strong Team Importance (00:12:03)

62 episoder

Artwork
iconDel
 
Manage episode 382347669 series 3526490
Indhold leveret af Vial. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Vial eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Embark on a journey into the forefront of biotech with Lucas Siow, the visionary behind ProteinQure, as he unveils the impact of his computational platform on peptide therapeutics and delves into the art of team building. Explore the fusion of medicinal chemistry and high throughput screens, discover the essence of benchmarking in drug discovery, and gain insights into creating a versatile, learning-focused team in the biotech landscape from their Toronto base.
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.

Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.
🎧 Stay in the Loop!
For the latest news and updates, visit our website: https://vial.com
Follow us on social media for real-time insights:
Twitter: https://twitter.com/VialTrials
LinkedIn: https://www.linkedin.com/company/vialtrials

  continue reading

Kapitler

1. Episode 39: Lucas Siow - CEO & Co-Founder at ProteinQure (00:00:00)

2. Advancing Peptide Therapeutics in Biotech (00:00:06)

3. Building a Strong Team Importance (00:12:03)

62 episoder

Wszystkie odcinki

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning